Targeting the PI3K/AKT/mTOR/NFκB Axis in Ovarian Cancer

Ovarian cancer stands as the most lethal gynecologic malignancy and remains the fifth most common gynecologic cancer. Poor prognosis and low five-year survival rate are attributed to nonspecific symptoms at early phases along with a lack of effective treatment at advanced stages. It is thus paramoun...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghoneum, Alia, Abdulfattah, Ammar Yasser, Said, Neveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213295/
https://www.ncbi.nlm.nih.gov/pubmed/32395722
http://dx.doi.org/10.33696/immunology.1.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213295/
https://www.ncbi.nlm.nih.gov/pubmed/32395722
http://dx.doi.org/10.33696/immunology.1.022

Ejemplares similares